SCHOTT Pharma KGaA Future Growth
Future criteria checks 2/6
SCHOTT Pharma KGaA is forecast to grow earnings and revenue by 16.9% and 11% per annum respectively. EPS is expected to grow by 17% per annum. Return on equity is forecast to be 19.2% in 3 years.
Key information
16.9%
Earnings growth rate
17.0%
EPS growth rate
| Life Sciences earnings growth | 25.5% |
| Revenue growth rate | 11.0% |
| Future return on equity | 19.2% |
| Analyst coverage | Good |
| Last updated | 14 Aug 2024 |
Recent future growth updates
Recent updates
Is There An Opportunity With SCHOTT Pharma AG & Co. KGaA's (ETR:1SXP) 31% Undervaluation?
Aug 07
Earnings Miss: SCHOTT Pharma AG & Co. KGaA Missed EPS By 18% And Analysts Are Revising Their Forecasts
Jul 01We Think SCHOTT Pharma KGaA (ETR:1SXP) Can Stay On Top Of Its Debt
Jun 07Calculating The Intrinsic Value Of SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Mar 28Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2026 | 1,216 | 211 | 91 | 254 | 9 |
| 9/30/2025 | 1,072 | 161 | 38 | 225 | 10 |
| 9/30/2024 | 967 | 145 | 21 | 210 | 9 |
| 3/31/2024 | 916 | 135 | -3 | 175 | N/A |
| 12/31/2023 | 906 | 158 | 37 | 220 | N/A |
| 9/30/2023 | 899 | 152 | 6 | 182 | N/A |
| 6/30/2023 | 873 | 143 | 70 | 215 | N/A |
| 9/30/2022 | 821 | 125 | 29 | 182 | N/A |
| 9/30/2021 | 649 | 101 | 34 | 132 | N/A |
| 9/30/2020 | 584 | 77 | 19 | 104 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1SXP's forecast earnings growth (16.9% per year) is above the savings rate (0.8%).
Earnings vs Market: 1SXP's earnings (16.9% per year) are forecast to grow slower than the German market (20% per year).
High Growth Earnings: 1SXP's earnings are forecast to grow, but not significantly.
Revenue vs Market: 1SXP's revenue (11% per year) is forecast to grow faster than the German market (5.3% per year).
High Growth Revenue: 1SXP's revenue (11% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 1SXP's Return on Equity is forecast to be low in 3 years time (19.2%).